Consistently, the NRF2 target gene, aldose ketose reductase family 1 member B10 (AKR1B10), was also reported as a reliable biomarker for smoking in lung cancers, and its expression is a good surrogate for NRF2 activation in lung cancer29,30. Here, NFE2L2 is linked to lung cancer.